MIRM 240816 50.00C (MIRM240816C50000) Stock Options, News & Quotes

US OptionsDetailed Quotes

MIRM240816C50000

Watchlist

0.75
-0.05-6.25%

15min DelayClose Aug 9 16:00 ET

0.75High0.75Low

Intraday

5D
Daily

News

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Yahoo FinanceAug 10 08:35 ET
Mirum Pharmaceuticals (MIRM) Receives a Buy From Evercore ISI
TipRanksAug 8 10:04 ET · Ratings
Optimistic Buy Rating for Mirum Pharmaceuticals Amidst Strong Sales Growth and Expanded LIVMARLI Label
TipRanksAug 8 09:55 ET · Ratings
Mirum Pharmaceuticals Price Target Raised to $66.00/Share From $62.00 by Evercore ISI Group
Dow JonesAug 8 09:20 ET · Ratings
Mirum Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group
Dow JonesAug 8 09:20 ET
Express News | Baird Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $44
BenzingaAug 8 07:59 ET

Comments

TrendTrader

Jul 26 14:17

Looking for 45, 47 and 50

$Mirum Pharmaceuticals (MIRM.US)$

Mark Livermore

Jul 7 23:26

Watchlist

$Mirum Pharmaceuticals (MIRM.US)$
PROS-IPO on Jul 2019; triple digit on recent quarterly sales; ADR6.4%; dollar average volume>10MM; interesting volume; ATH; RS rating=89; near time high.
CONS-might need to wait for 10MA to catch up.
$iLearningEngines (AILE.US)$
PROS-IPO on Apr 2024 after business combination; AI theme; ADR12.33%; price increased approximately 90% in 1 month and sideway consolidate, building higher low and surphing 10 MA; vol drying up.
CONS-dollar volume between 1MM to 5...

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Meltyy

Mar 11 22:36

4 PDUFA decisions this week!

Last week’s PDUFAs:
$BeiGene (BGNE.US)$ : Approved 3/8 🎉
⇒ BRUKINSA + obinutuzumab
⇒ Follicular Lymphoma
⇒ sNDA
⇒ PDUFA date: Mar 2024
$Bristol-Myers Squibb (BMY.US)$ : Approved 3/8 🎉
⇒ Opdivo ® + Cisplatin & Gemcitabine
⇒ Urothelial carcinoma
⇒ sBLA
⇒ PDUFA: 04/05/24
$Vanda Pharmaceuticals (VNDA.US)$ : CRL 3/4 🙁
⇒ HETLIOZ®
⇒ insomnia
⇒ sNDA
⇒ PDUFA: 03/04/24
$Eyenovia (EYEN.US)$ : Approved 3/4 🎉
⇒ Clobetasol propionate ophthalmic susp. 0.05% (APP13007)
⇒ postop eye pa...

Meltyy

Feb 27 21:34

FDA Calendar-March

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Eyenovia (EYEN.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $Mirum Pharmaceuticals (MIRM.US)$ $Madrigal Pharmaceuticals (MDGL.US)$ $Geron (GERN.US)$ $Bristol-Myers Squibb (BMY.US)$ $2seventy bio (TSVT.US)$ $Legend Biotech (LEGN.US)$ $OptiNose (OPTN.US)$ $Orchard Therapeutics (ORTX.US)$ $Merck & Co (MRK.US)$ $Akebia Therapeutics (AKBA.US)$ $AstraZeneca (AZN.US)$ $Liquidia (LQDA.US)$ $Esperion Therapeutics (ESPR.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $BeiGene (BGNE.US)$